The IARC TP53 database: New online mutation analysis and recommendations to users

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463

p53 and Human Cancer: The First Ten Thousand Mutations

Hainaut, P. L., & Hollstein, M. C. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60785-x · Cited by 999

Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome

Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899

Database of p53 gene somatic mutations in human tumors and cell lines.

Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 858

Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73

Strano, S., Munarriz, E. R., Rossi, M., Cristofanelli, B., Shaul, Y., Castagnoli, L., Levine, A. J., Sacchi, A., Cesareni, G., Oren, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003360200 · Cited by 241

p53 gene mutation: software and database

Béroud, C. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.1.147 · Cited by 185

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.

Vahteristo, P., Tamminen, A., Karvinen, P., Eerola, H., Eklund, C., Aaltonen, L. A., BLOMQVIST, C. P., Aittomäki, K., & Nevanlinna, H. A. (2001) · PubMed · Cited by 180

p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer

Hussain, S. P., & Harris, C. C. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s1383-5742(99)00028-9 · Cited by 164

p53 and the Li-Fraumeni syndrome

Malkin, D. M. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90233-c · Cited by 153

p53 gene mutation: software and database

Béroud, C. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.1.200 · Cited by 149

Progress toward Better Treatment of Therapy-Related AML

Kotsiafti, A., Giannakas, K., Christoforou, P., & Liapis, K. (2023) · Cancers · doi:10.3390/cancers15061658 · Cited by 18

A noncanonical IRAK4-IRAK1 pathway counters DNA damage–induced apoptosis independently of TLR/IL-1R signaling

Li, Y., Shah, R. B., Sarti, S., Belcher, A. L., Lee, B. J., Gorbatenko, A., Nemati, F., Yu, H., Stanley, Z., Rahman, M., et al. (2023) · Science Signaling · doi:10.1126/scisignal.adh3449 · Cited by 19

The anti‐tumour compound, RH1, causes mitochondria‐mediated apoptosis by activating c‐Jun N‐terminal kinase

Park, M., Song, M.-J., Oh, E., Lee, H., Choi, B., Jeong, S., Choi, E., & Park, H. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01233.x · Cited by 17

Utilising ion mobility-mass spectrometry to interrogate macromolecules: Factor H complement control protein modules 10–15 and 19–20 and the DNA-binding core domain of tumour suppressor p53

Faull, P. A., Florance, H., Schmidt, C. Q., Tomczyk, N., Barlow, P. N., Hupp, T. R., Nikolova, P. V., & Barran, P. E. (2010) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2010.01.007 · Cited by 17

Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: Fluorescence in situ hybridization and cytogenetic studies

Demirhan, O., Korkmaz, D. T., Hastürk, S., Kuleci, S., & Hanta, İ. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.03.018 · Cited by 17

Structural and functional implications of p53 missense cancer mutations

Tan, Y.-H., & Luo, R. (2009) · PMC Biophysics · doi:10.1186/1757-5036-2-5 · Cited by 17

Next generation sequencing is informing phenotype: a TP53 example

O’Shea, R., Clarke, R. C., Berkley, E., Giffney, C., Farrell, M., O’Donovan, E. M., & Gallagher, D. J. (2017) · Familial Cancer · doi:10.1007/s10689-017-0002-1 · Cited by 17

Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families

Dominguez-Valentin, M., Nakken, S., Tubeuf, H., Vodák, D., Ekstrøm, P. O., Nissen, A. M., Morak, M., Holinski-Feder, E., Martins, A., Møller, P., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-0011-0 · Cited by 14

Unraveling the Allosteric Mechanism of Four Cancer-related Mutations in the Disruption of p53-DNA Interaction

Tang, Y., Yao, Y., & Wei, G. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c05638 · Cited by 18

The contribution of molecular epidemiology to the identification of human carcinogens: current status and future perspectives

Boffetta, P., & Islami, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds543 · Cited by 17

p53 Replacement Therapy for Cancer

Tazawa, H., Kagawa, S., & Fujiwara, T. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42934-2_1 · Cited by 16

Quercetin Triggers Induction of Apoptotic and Lysosomal Death of Sensitive and Multidrug Resistant Leukaemia HL60 Cells

Maruszewska, A., & Tarasiuk, J. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1752745 · Cited by 17

Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs)

Gorlov, I. P., Gorlova, O. Y., Frazier, M. L., & Amos, C. I. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.04.014 · Cited by 17

Mouse models with modified p53 sequences to study cancer and ageing

Clarke, A. R., & Hollstein, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401188 · Cited by 17

The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins

Ma, B., Pan, Y., Gunasekaran, K., Keskin, Ö., Venkataraghavan, R. B., Levine, A. J., & Nussinov, R. (2005) · Physical Biology · doi:10.1088/1478-3975/2/2/s06 · Cited by 17

Targeting p53 gain-of-function activity in cancer therapy: a cautionary tale

Attardi, L. D., & Boutelle, A. M. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01253-7 · Cited by 22

A cost-effective, analytical method for measuring metabolic load of mitochondria

Grey, J. F. E., Townley, A. R., Everitt, N. M., Campbell-Ritchie, A., & Wheatley, S. P. (2019) · Metabolism Open · doi:10.1016/j.metop.2019.100020 · Cited by 16

Study of optical properties of gold nanoparticles embedded in normal, benign, and malignant breast tissues

Akouibaa, A., Masrour, R., Jabar, A., BENHAMOU, M., & Derouiche, A. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130979 · Cited by 16

Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform

Lin, E., Hahn, A. W., Nussenzveig, R. H., Wesołowski, S., Sayegh, N., Maughan, B. L., McFarland, T. R., Rathi, N., Sirohi, D., Sonpavde, G., et al. (2021) · The Oncologist · doi:10.1002/onco.13869 · Cited by 16

MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway

Aersilan, A., Hashimoto, N., Yamagata, K., Yokoyama, M., Nakayama, A., Shi, X., Nagano, H., Sakuma, I., Nohata, N., Kinoshita, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23205-w · Cited by 16

Colorectal carcinomas from Middle East. Molecular and tissue microarray analysis of genomic instability pathways

Bavi, P. P., Abubaker, J. A., Jehan, Z., Al-Jomah, N. A., Siraj, A. K., Al-harbi, S., Atizado, V., Abduljabbar, A. S., Alhomoud, S. J., Ashari, L. H. S., et al. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4193 · Cited by 16

p53 functions and cell lines: Have we learned the lessons from the past?

Millau, J., Mai, S., Bastien, N., & Drouin, R. (2010) · BioEssays · doi:10.1002/bies.200900160 · Cited by 16

Recombinant, refolded tetrameric p53 and gonadotropin-releasing hormone-p53 slow proliferation and induce apoptosis in p53-deficient cancer cells

LaFevre-Bernt, M. A., Wu, S., & Lin, X. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0078 · Cited by 16

Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus

Lacerda, C. F., Cruvinel‐Carloni, A., de Oliveira, A. T. T., Scapulatempo‐Neto, C., López, R. V. M., Crema, E., Adad, S. J., Rodrigues, M. A. M., Henry, M. A. C. A., Guimarães, D. P., et al. (2017) · Diseases of the Esophagus · doi:10.1093/dote/dow040 · Cited by 16

Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort

Akter, H., Sultana, N., Martuza, N., Siddiqua, A., Dity, N. J., Rahaman, A., Samara, B., Sayeed, A., Basiruzzaman, M., Rahman, M., et al. (2019) · BMC Medical Genetics · doi:10.1186/s12881-019-0881-0 · Cited by 16

Nabe: an energetic database of amino acid mutations in protein–nucleic acid binding interfaces

Liu, J., Liu, S., Liu, C., Zhang, Y., Pan, Y., Wang, Z., Wang, J., Wen, T., & Deng, L. (2021) · Database · doi:10.1093/database/baab050 · Cited by 16

Discrimination of single amino acid mutations of the p53 protein by means of deterministic singularities of recurrence quantification analysis

Porrello, A., Soddu, S., Zbilut, J. P., Crescenzi, M., & Giuliani, A. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20075 · Cited by 16

p53 Expression in MCF7, T47D and MDA-MB 468 Breast Cancer Cell Lines Treated with Adriamycin Using RT-PCR and Immunocytochemistry

Kaabinejadian, S., Fouladdel, S., Ramezani, M., & Azizi, E. (2008) · Journal of Biological Sciences · doi:10.3923/jbs.2008.380.385 · Cited by 16

TP53 Mutation Spectrum in Lung Cancer Is Not Different in Women and Men

Marrogi, A. J., Mechanic, L. E., Welsh, J. A., Bowman, E. D., Ma, K., Enewold, L., Shields, P. G., & Harris, C. C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0640 · Cited by 16

TP53 codon 72 polymorphism and glioma risk: A meta-analysis

Shi, M., HUANG, R., PEI, C., Jia, X., Jiang, C., & Ren, H. (2011) · Oncology Letters · doi:10.3892/ol.2011.521 · Cited by 16

Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation

Rossbach, H., Baschinsky, D. Y., Wynn, T., Obzut, D. A., Sutcliffe, M. J., & Tebbi, C. K. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21219 · Cited by 16

TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset

Pinto, C., Veiga, I., Pinheiro, M., Peixoto, A., Pinto, A., Lopes, J. M., Reis, R. M., Oliveíra, C., Baptista, M., Roque, L., et al. (2009) · Familial Cancer · doi:10.1007/s10689-009-9251-y · Cited by 16

p53 Pre- and Post-Binding Event Theories Revisited: Stresses Reveal Specific and Dynamic p53-Binding Patterns on the p21 Gene Promoter

Millau, J., Bastien, N., Bouchard, É. F., & Drouin, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2036 · Cited by 16

Analysis of chromosome 10 aberrations in rat endometrial cancer—evidence for a tumor suppressor locus distal to Tp53

Nordlander, C., Karlsson, S., Karlsson, A. E., Sjöling, Å., Winnes, M., Klinga‐Levan, K., & Behboudi, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22533 · Cited by 16

P53 mutations in tissue from Danish ovarian cancer patients

Høgdall, E. V. S., Kjær, S. K., Blaakær, J., Christensen, L. H., Glud, E., Vuust, J., & Høgdall, C. K. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.07.131 · Cited by 16

TP53 Cancerous Mutations Exhibit Selection for Translation Efficiency

Waldman, Y. Y., Tuller, T., Sharan, R., & Ruppin, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1653 · Cited by 16

High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan

Chen, F., Hou, M., Wang, J., Chen, T., Chen, D. C. P., Huang, S., Chung, Y.-S., & Lin, S. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.12.005 · Cited by 16

Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand

Galy, O., Chemin, I., Roux, E. L., Villar, S., Calvez‐Kelm, F. L., Lereau, M., Gouas, D. A., Vieco, B., Mellado, I. S., Navas, M. C., et al. (2011) · Hepatitis Research and Treatment · doi:10.1155/2011/697162 · Cited by 16

Nitric oxide prevents UV-induced phosphorylation of the p53 tumor-suppressor protein at serine 46: a possible role in inhibition of apoptosis

Fukunaga‐Takenaka, R., Fukunaga, K., Tatemichi, M., & Ohshima, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01516-x · Cited by 16

Liquid chromatography

Sharma, V. K. (2012) · doi:10.17760/d20002778 · Cited by 16

From experimental studies to computational approaches: recent trends in designing novel therapeutics for amyloidogenesis

Ghosh, P., Kundu, A., & Ganguly, D. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01890g · Cited by 15

Li–Fraumeni syndrome in a Malaysian kindred

Ariffin, H., Martel‐Planche, G., Daud, S. S., Ibrahim, K., & Hainaut, P. L. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.06.004 · Cited by 15

Genetic Variations in MDM2 and P53 Genes Confer Risk for Adult Acute Lymphoblastic Leukemia in a Chinese Population

Chen, J., Zhu, B., Chen, J., & Li, Y. (2013) · DNA and Cell Biology · doi:10.1089/dna.2012.1900 · Cited by 15

Tumor-specific induction of apoptosis by a p53-reactivating compound

Hedström, E., Issaeva, N., Enge, M., & Selivanova, G. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.009 · Cited by 15

Li–Fraumeni and Li–Fraumeni‐like syndrome mutations in p53 are associated with exonic methylation and splicing regulatory elements

Kouidou, S., Malousi, A., & Maglaveras, N. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20537 · Cited by 15

Toxicology of DNA Adducts Formed Upon Human Exposure to Carcinogens

Wilson, K. A., Kung, R. W., & Wetmore, S. D. (2016) · Advances in molecular toxicology · doi:10.1016/b978-0-12-804700-2.00007-6 · Cited by 15

Harnessing the vulnerabilities of p53 mutants in lung cancer – Focusing on the proteasome: a new trick for an old foe?

Oduah, E., & Grossman, S. R. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1702403 · Cited by 16

Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53–R175H mutant aggregation

Lei, J., Cai, M., Shen, Y., Lin, D., & Deng, X. (2021) · Physical Chemistry Chemical Physics · doi:10.1039/d1cp03094a · Cited by 15

Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer

Mallick, A. M., Biswas, A., Mishra, S., Jadhav, S., Chakraborty, K., Tripathi, A., Mukherjee, A., & Roy, R. S. (2023) · Chemical Science · doi:10.1039/d3sc01071f · Cited by 15

An integrated network-based mechanistic model for tumor growth dynamics under drug administration

Ribeiro, D., & Pinto, J. M. (2009) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2009.01.014 · Cited by 15

Late-Onset Common Cancers in a Kindred with an Arg213Gln TP53 Germline Mutation

Ruijs, M., Verhoef, S., Wigbout, G., Pruntel, R., Floore, A. N., de Jong, D., Veer, L. V. ‘., & Menko, F. H. (2006) · Familial Cancer · doi:10.1007/s10689-005-4789-9 · Cited by 15

Assessment of the Transcriptional Activity of p53 Improves the Prediction of Recurrence in Superficial Transitional Cell Carcinoma of the Bladder

Dekairelle, A., TOMBAL, B. F., Cosyns, J., & Gala, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0140 · Cited by 15

Frequent recovery of triplet mutations in UVB-exposed skin epidermis of Xpc-knockout mice

Ikehata, H., Saito, Y., Yanase, F., Mori, T., Nikaido, O., & Ono, T. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.09.003 · Cited by 15

Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk

Kaufmann, W. K., Filatov, L. V., Oglesbee, S. E., Simpson, D. A., Lotano, M. A., McKeen, H. D., Sawyer, L., Moore, D. T., Millikan, R. C., Cordeiro‐Stone, M., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl103 · Cited by 14

Extract from Asteraceae Brachylaena ramiflora induces apoptosis preferentially in mutant p53-expressing human tumor cells

Karimi, M., Conserva, F., Mahmoudi, S., Bergman, J., Wiman, K. G., & Bykov, V. J. N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq084 · Cited by 15

p53 mutations are common in human papillomavirus type 38-positive non-melanoma skin cancers

Caldeira, S., Filotico, R., Accardi, R., Zehbe, I., Franceschi, S., & Tommasino, M. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.12.003 · Cited by 15

Regulation of IFN-γ-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications

Guo, L., Tang, X., Wong, S. W., Guo, A., Lin, Y., & Kwok, H. F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1022129 · Cited by 15

AI-powered discovery of a novel p53-Y220C reactivator

Zhou, S., Chai, D., Wang, X., Neeli, P. K., Yu, X., Davtyan, A., Young, K. H., & Li, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1229696 · Cited by 14

Streptavidin-enhanced assay for sensitive and specific detection of single nucleotide polymorphism in TP53

Šípová, H., Špringer, T., & Homola, J. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3863-9 · Cited by 14

The Arg72 variant of the p53 functional polymorphism (rs1042522) is associated with coronary artery disease in young South Africans of Indian ancestry

Khan, S., Phulukdaree, A., Ramkaran, P., Moodley, D., & Chuturgoon, A. A. (2016) · Gene · doi:10.1016/j.gene.2016.07.040 · Cited by 14

The Individual Cell Properties of Oral Squamous Cell Carcinoma and p53 Tumor Suppressor Gene Mutation

Kamiya, Y., & Ohshima, T. (2005) · Oral Science International · doi:10.1016/s1348-8643(05)80013-8 · Cited by 14

Murine Gammaherpesvirus 68 LANA and SOX Homologs Counteract ATM-Driven p53 Activity during Lytic Viral Replication

Sifford, J. M., Stahl, J. A., Salinas, E., & Forrest, J. C. (2015) · Journal of Virology · doi:10.1128/jvi.02867-15 · Cited by 12

Assays to Measure p53-Dependent and -Independent Apoptosis

Phillips, D. C., Garrison, S. P., Jeffers, J. R., & Zambetti, G. P. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-017-5_11 · Cited by 14

Radiation-induced cutaneous carcinoma of the head and neck: is there an early role for p53 mutations?

Franchi, A., Massi, D., Gallo, O., Santucci, M., & Porfirio, B. (2006) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2006.02218.x · Cited by 14

Genome Wide Identification of Recessive Cancer Genes by Combinatorial Mutation Analysis

Volinia, S., Mascellani, N., Marchesini, J., Veronese, A., Ormondroyd, E., Alder, H., Palatini, J., Negrini, M., & Croce, C. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003380 · Cited by 14

Combined Analysis of Smoking,TP53, andFGFR3Mutations in Tunisian Patients with Invasive and Superficial High-Grade Bladder Tumors

Ouerhani, S., Rouissi, K., Kourda, N., Marrakchi, R., Bougatef, K., Slama, M. R. B., Sfaxi, M., Chébil, M., Jilani, S. B., & Elgaaïed, A. B. (2009) · Cancer Investigation · doi:10.3109/07357900902849707 · Cited by 14

Potential of Advexin ® : A p53 Gene-Replacement Therapy in Li–Fraumeni Syndrome

Nemunaitis, J., & Nemunaitis, J. J. (2008) · Future Oncology · doi:10.2217/14796694.4.6.759 · Cited by 14

Cancer of the Breast

Abeloff, M. D., Wolff, A. C., Weber, B. L., Zaks, T. Z., Sacchini, V., & McCormick, B. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50099-3 · Cited by 14

Somatic genetics of testicular cancer in relationship to prognosis

Nathanson, K. L., & Vaughn, D. J. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.11.1298 · Cited by 14

Aromatic Amines and Heterocyclic Aromatic Amines: From Tobacco Smoke to Food Mutagens

Turesky, R. J. (2010) · Wiley eBooks · doi:10.1002/9783527630110.ch7 · Cited by 14

Dual Modulators of p53 and Cyclin D in ER Alpha Signaling by Albumin Nanovectors Bearing Zinc Chaperones for ER-positive Breast Cancer Therapy

Sundar, P. S., Naresh, P., Justin, A., Wadhwani, A., Mohankumar, S. K., & Selvaraj, J. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520999201124212347 · Cited by 13

DNA-lesion mapping in mammalian cells

Nia, A. B., & Pfeifer, G. P. (2009) · Methods · doi:10.1016/j.ymeth.2009.02.008 · Cited by 13

Nicotine Promotes WRL68 Cells Proliferation Due to the Mutant p53 Gain-of-Function by Activating CDK6-p53-RS-PIN1-STAT1 Signaling Pathway

Wang, H., Chen, L., Zhou, T., Zhang, Z., & Zeng, C. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00119 · Cited by 13

Mutation enrichment in human DNA samples via UV-mediated cross-linking

Leong, K. W., Yu, F., & Makrigiorgos, G. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1222 · Cited by 13

Detection of single nucleotide polymorphisms by minisequencing on a polypyrrole DNA chip designed for medical diagnosis

Ho-Pun-Cheung, A., Choblet, S., Colineau, T., Abaibou, H., Zsoldos, D., Brengel‐Pesce, K., Grenier, J., Cleuziat, P., & Lopez‐Crapez, E. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700387 · Cited by 13

Expression of a Mutant p53 Results in an Age-Related Demographic Shift in Spontaneous Lung Tumor Formation in Transgenic Mice

Duan, W., Gao, L., Wu, X., Hade, E. M., Gao, J., Ding, H., Barsky, S. H., Otterson, G. A., & Villalona-Calero, M. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005563 · Cited by 13

Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis

Tarafa, G., Tuck, D. P., Ladner, D. P., Topazian, M. D., Brand, R. E., Deters, C. A., Moreno, V. R., Capellá, G., Lynch, H. T., Lizardi, P. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708250105 · Cited by 13

Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis

Dreidax, D., Gogolin, S., Schroeder, C., Muth, D., Brueckner, L. M., Hess, E. M., Zapatka, M., Theißen, J., Fischer, M., Ehemann, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt020 · Cited by 13

p53 status correlates with histopathological response in patients with soft tissue sarcomas treated using isolated limb perfusion with TNF-α and melphalan

Muret, J. C., Yacoub, M., Terrier, P., Drusch, F., Laplanche, A., Gaudin, C., Richon, C., Pechoux, C. L., Cesne, A. L., Lejeune, F. J., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm559 · Cited by 13

Low density DNA microarray for detection of most frequent TP53 missense point mutations

Rangel-López, A., Maldonado‐Rodríguez, R., Salcedo–Vargas, M., Espinosa-Lara, J. M., Méndez-Tenorio, A., & Beattie, K. L. (2005) · BMC Biotechnology · doi:10.1186/1472-6750-5-8 · Cited by 13

Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.

Franekova, M., Žúbor, P., Štanclová, A., Ca, D., Bohušová, T., Galo, S., Dobrota, D., Kajo, K., M, P., & Račay, P. (2007) · PubMed · Cited by 13

The Discovery of Cryptic Pockets Increases the Druggability of “Undruggable” Proteins

Mou, M., Yang, W., Huang, G., Yang, X., Zhang, X. L., Kandegama, W., Ashby, C. R., Hao, G., & Gao, Y. (2025) · Medicinal Research Reviews · doi:10.1002/med.70001 · Cited by 14

Anticancer therapeutic strategies for targeting mutant p53-Y220C

Chasov, V. V., Davletshin, D., Gilyazova, E., Mirgayazova, R., Kudriaeva, A. A., Khadiullina, R., Yuan, Y., & Bulatov, E. (2023) · Journal of Biomedical Research · doi:10.7555/jbr.37.20230093 · Cited by 13

A Bioinformatics Toolkit for Next-Generation Sequencing in Clinical Oncology

Cabello‐Aguilar, S., Vendrell, J. A., & Solassol, J. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45120608 · Cited by 16

Increased Risk of Cutaneous Melanoma Associated with p53 Arg72Pro Polymorphism

Geng, P., Liao, Y., Ruan, Z., & Liang, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118112 · Cited by 12

Altered Pathway Analyzer: A gene expression dataset analysis tool for identification and prioritization of differentially regulated and network rewired pathways

Kaushik, A., Ali, S., & Gupta, D. K. (2017) · Scientific Reports · doi:10.1038/srep40450 · Cited by 13

Structured Penalized Regression for Drug Sensitivity Prediction

Zhao, Z. Q., & Zucknick, M. (2020) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/rssc.12400 · Cited by 13

Deciphering the mechanisms of HPV E6 mutations in the destabilization of E6/E6AP/p53 complex

Li, L., Dong, X., Tang, Y., Lao, Z., Li, X., Lei, J., & Wei, G. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.03.030 · Cited by 11

Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties

McCubrey, J. A., Meher, A. K., Akula, S. M., Abrams, S. L., Steelman, L. S., LaHair, M. M., Franklin, R. A., Martelli, A. M., Ratti, S., Cocco, L., et al. (2022) · Aging · doi:10.18632/aging.204038 · Cited by 12

Evaluating the Association between p53 Codon 72 Arg>Pro Polymorphism and Risk of Ovary Cancer: A Meta-Analysis

Alqumber, M. A. A., Akhter, N., Haque, S., Panda, A. K., & Mandal, R. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094874 · Cited by 12

Dipeptide analysis of p53 mutations and evolution of p53 family proteins

Huang, Q., Yu, L., Levine, A. J., Nussinov, R., & Ma, B. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.04.002 · Cited by 11

Transcriptional Landscape of PARs in Epithelial Malignancies

Nag, J. K., & Bar‐Shavit, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113451 · Cited by 12

T-cell large granular lymphocyte leukemia transfomation into aggressive T-cell lymphoma: a report of two cases with molecular characterization

Belhadj, M., Mansour, D., Kaltenbach, S., Deau, B., Franchi, P., Tamburini, J., Chapuis, N., Damotte, D., Kosmider, O., Burroni, B., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.205542 · Cited by 12

Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients

Zhu, C., Zhu, L., Gu, Y., Liu, P., Tong, X., Wu, G., Zhu, W., Shen, W., Bao, H., Ma, X., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.608742 · Cited by 12

Successful Treatment of an Unresectable Choroid Plexus Carcinoma in a Patient With Li-Fraumeni Syndrome

Dickens, D. S., Dothage, J. A., Heideman, R. L., Ballard, E. T., & Jubinsky, P. T. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000152569.60694.1f · Cited by 12

QM-MM simulations on p53-DNA complex: a study of hot spot and rescue mutants

Koulgi, S., Achalere, A., Sharma, N., Sonavane, U., & Joshi, R. (2013) · Journal of Molecular Modeling · doi:10.1007/s00894-013-2042-2 · Cited by 11

Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China

Dai, M., Zhang, W., Clifford, G. M., Gheit, T., He, B., Michael, K. M., Waterboer, T., Hainaut, P. L., Tommasino, M., & Franceschi, S. (2007) · International Journal of Cancer · doi:10.1002/ijc.22824 · Cited by 12

Vermont: a multi-perspective visual interactive platform for mutational analysis

Fassio, A. V., Martins, P., Guimarães, S. D. S., Sócrates, S. A., Ribeiro, V. S., de Melo-Minardi, R. C., & Silveira, S. D. A. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1789-3 · Cited by 11

Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case–Control Study and In Silico Analyses

Biglari-Zadeh, G., Sargazi, S., Mohammadi, M., Ghasemi, M., Majidpour, M., Saravani, R., & Mirinejad, S. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10349-1 · Cited by 11

The IARC TP53 mutation database: a resource for studying the significance of TP53 mutations in human cancers

Olivier, M., Hainaut, P. L., & Petitjean, A. (2007) · IATREIA

IARC TP53 Database

Olivier, M., & Hainaut, P. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_2934 · Cited by 1

Untitled work

(1999) · doi:10.1002/(sici)1098-1004(1999)14:1

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data: Human Mutation

Bouaoun, L., Sonkin, D., Ardin, M., Hollstein, M., Byrnes, G., Zavadil, J., & Olivier, M. (2016) · Human Mutation · doi:10.1002/humu.23035 · Cited by 730

Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects

Hainaut, P. L., Soussi, T., Shomer, B., Hollstein, M. C., Greenblatt, M. S., Hovig, E. J., Harris, C. C., & Montesano, R. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.1.151 · Cited by 299